nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—myenteric nerve plexus—Parkinson's disease	0.111	0.237	CbGeAlD
Cysteamine—SST—autonomic nervous system—Parkinson's disease	0.0513	0.11	CbGeAlD
Cysteamine—SST—peripheral nervous system—Parkinson's disease	0.037	0.0791	CbGeAlD
Cysteamine—NPY2R—forebrain—Parkinson's disease	0.0306	0.0655	CbGeAlD
Cysteamine—SST—nerve—Parkinson's disease	0.0288	0.0617	CbGeAlD
Cysteamine—SST—hindbrain—Parkinson's disease	0.0216	0.0462	CbGeAlD
Cysteamine—NPY2R—head—Parkinson's disease	0.0175	0.0375	CbGeAlD
Cysteamine—NPY2R—nervous system—Parkinson's disease	0.0166	0.0355	CbGeAlD
Cysteamine—NPY2R—central nervous system—Parkinson's disease	0.016	0.0342	CbGeAlD
Cysteamine—SST—embryo—Parkinson's disease	0.0135	0.0289	CbGeAlD
Cysteamine—NPY2R—brain—Parkinson's disease	0.0127	0.0272	CbGeAlD
Cysteamine—SST—brainstem—Parkinson's disease	0.0124	0.0265	CbGeAlD
Cysteamine—SST—forebrain—Parkinson's disease	0.0119	0.0256	CbGeAlD
Cysteamine—SST—cardiovascular system—Parkinson's disease	0.0101	0.0216	CbGeAlD
Cysteamine—SST—medulla oblongata—Parkinson's disease	0.00863	0.0185	CbGeAlD
Cysteamine—SST—midbrain—Parkinson's disease	0.00789	0.0169	CbGeAlD
Cysteamine—SST—spinal cord—Parkinson's disease	0.0077	0.0165	CbGeAlD
Cysteamine—SST—head—Parkinson's disease	0.00684	0.0146	CbGeAlD
Cysteamine—SST—nervous system—Parkinson's disease	0.00649	0.0139	CbGeAlD
Cysteamine—SST—central nervous system—Parkinson's disease	0.00624	0.0134	CbGeAlD
Cysteamine—SST—cerebellum—Parkinson's disease	0.0061	0.0131	CbGeAlD
Cysteamine—SST—brain—Parkinson's disease	0.00496	0.0106	CbGeAlD
Cysteamine—MPO—forebrain—Parkinson's disease	0.00481	0.0103	CbGeAlD
Cysteamine—MPO—cardiovascular system—Parkinson's disease	0.00407	0.0087	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00391	0.00735	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00363	0.00682	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00359	0.00673	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00348	0.00653	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00342	0.00642	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—INSR—Parkinson's disease	0.00335	0.00629	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00334	0.00628	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00332	0.00623	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00321	0.00602	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00318	0.00598	CbGpPWpGaD
Cysteamine—MPO—spinal cord—Parkinson's disease	0.0031	0.00663	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—DRD1—Parkinson's disease	0.00301	0.00564	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00294	0.00551	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—GRM4—Parkinson's disease	0.00292	0.00548	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—DRD3—Parkinson's disease	0.00291	0.00546	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00289	0.00542	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD1—Parkinson's disease	0.00289	0.00542	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00286	0.00538	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GRM4—Parkinson's disease	0.0028	0.00525	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00279	0.00523	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PENK—Parkinson's disease	0.00276	0.00519	CbGpPWpGaD
Cysteamine—MPO—head—Parkinson's disease	0.00276	0.00589	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00275	0.00516	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00268	0.00503	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TH—Parkinson's disease	0.00268	0.00503	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00266	0.005	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PENK—Parkinson's disease	0.00265	0.00498	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—HTR7—Parkinson's disease	0.00263	0.00494	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—DRD2—Parkinson's disease	0.00263	0.00494	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00262	0.00493	CbGpPWpGaD
Cysteamine—MPO—nervous system—Parkinson's disease	0.00261	0.00559	CbGeAlD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD2—Parkinson's disease	0.0026	0.00488	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00257	0.00482	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00255	0.00478	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PDYN—Parkinson's disease	0.00253	0.00475	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00252	0.00472	CbGpPWpGaD
Cysteamine—MPO—central nervous system—Parkinson's disease	0.00251	0.00538	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00247	0.00465	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00247	0.00464	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00246	0.00462	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00242	0.00455	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PDYN—Parkinson's disease	0.00242	0.00455	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00242	0.00455	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00238	0.00448	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00236	0.00442	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—GRM5—Parkinson's disease	0.00235	0.00441	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD1—Parkinson's disease	0.00235	0.00441	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00232	0.00436	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00232	0.00436	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.0023	0.00432	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—MTHFR—Parkinson's disease	0.00229	0.0043	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00228	0.00428	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GRM5—Parkinson's disease	0.00225	0.00423	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00224	0.00421	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.0022	0.00414	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DGKQ—Parkinson's disease	0.0022	0.00413	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GPR37—Parkinson's disease	0.0022	0.00413	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.0022	0.00413	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00218	0.0041	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00216	0.00405	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00216	0.00405	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00215	0.00404	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—APOE—Parkinson's disease	0.00213	0.004	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00213	0.004	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD2—Parkinson's disease	0.00212	0.00397	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DGKQ—Parkinson's disease	0.00211	0.00396	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GPR37—Parkinson's disease	0.00211	0.00396	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00211	0.00396	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00204	0.00383	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—GPX1—Parkinson's disease	0.00202	0.00379	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00201	0.00378	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADORA2A—Parkinson's disease	0.002	0.00375	CbGpPWpGaD
Cysteamine—MPO—brain—Parkinson's disease	0.002	0.00427	CbGeAlD
Cysteamine—NPY2R—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00193	0.00362	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00193	0.00362	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00193	0.00362	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00192	0.0036	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00187	0.00351	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—MTHFR—Parkinson's disease	0.00186	0.0035	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00185	0.00347	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00185	0.00347	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GRK5—Parkinson's disease	0.00184	0.00345	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—INS—Parkinson's disease	0.00182	0.00342	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GRK5—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—Parkinson's disease	0.00176	0.0033	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.00174	0.00326	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR1A—Parkinson's disease	0.00173	0.00326	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—TAC1—Parkinson's disease	0.00171	0.00321	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00168	0.00316	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD1—Parkinson's disease	0.00167	0.00314	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GRK5—Parkinson's disease	0.00167	0.00313	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR1A—Parkinson's disease	0.00166	0.00312	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GRM4—Parkinson's disease	0.00165	0.00309	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—TAC1—Parkinson's disease	0.00164	0.00307	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD3—Parkinson's disease	0.00162	0.00305	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD1—Parkinson's disease	0.00161	0.00301	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.0016	0.00301	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GRK5—Parkinson's disease	0.0016	0.003	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GRM4—Parkinson's disease	0.00158	0.00297	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VPS35—Parkinson's disease	0.00157	0.00295	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PENK—Parkinson's disease	0.00156	0.00293	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD3—Parkinson's disease	0.00156	0.00292	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00154	0.0029	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00151	0.00283	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VPS35—Parkinson's disease	0.0015	0.00283	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PENK—Parkinson's disease	0.0015	0.00281	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GRM4—Parkinson's disease	0.0015	0.00281	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—INS—Parkinson's disease	0.00148	0.00278	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00148	0.00278	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00148	0.00278	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR7—Parkinson's disease	0.00147	0.00275	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—DRD2—Parkinson's disease	0.00147	0.00275	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GRM4—Parkinson's disease	0.00143	0.00269	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PDYN—Parkinson's disease	0.00143	0.00268	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PENK—Parkinson's disease	0.00142	0.00266	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD2—Parkinson's disease	0.00141	0.00264	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR7—Parkinson's disease	0.00141	0.00264	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.0014	0.00262	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00139	0.00261	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PDYN—Parkinson's disease	0.00137	0.00257	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PENK—Parkinson's disease	0.00136	0.00255	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00136	0.00255	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00135	0.00253	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GRM5—Parkinson's disease	0.00133	0.00249	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DGKQ—Parkinson's disease	0.0013	0.00244	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GPR37—Parkinson's disease	0.0013	0.00244	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PDYN—Parkinson's disease	0.0013	0.00244	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00129	0.00243	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—Parkinson's disease	0.00127	0.00239	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GRM5—Parkinson's disease	0.00127	0.00239	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GPR37—Parkinson's disease	0.00125	0.00234	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DGKQ—Parkinson's disease	0.00125	0.00234	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PDYN—Parkinson's disease	0.00124	0.00234	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GRM5—Parkinson's disease	0.00121	0.00226	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00119	0.00223	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—INS—Parkinson's disease	0.00118	0.00221	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—EDN1—Parkinson's disease	0.00117	0.00221	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GRM5—Parkinson's disease	0.00116	0.00217	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00114	0.00214	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00113	0.00212	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—EDN1—Parkinson's disease	0.00113	0.00211	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL1B—Parkinson's disease	0.00111	0.00208	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00108	0.00203	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RIT2—Parkinson's disease	0.00104	0.00195	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—Parkinson's disease	0.00103	0.00193	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR2A—Parkinson's disease	0.00103	0.00193	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00103	0.00193	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00101	0.0019	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—MAPK8—Parkinson's disease	0.001	0.00188	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RIT2—Parkinson's disease	0.000997	0.00187	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000986	0.00185	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRK5—Parkinson's disease	0.000986	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR2A—Parkinson's disease	0.000985	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000983	0.00185	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00098	0.00184	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—TAC1—Parkinson's disease	0.000965	0.00181	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD1—Parkinson's disease	0.000946	0.00178	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRK5—Parkinson's disease	0.000945	0.00177	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00094	0.00176	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—TAC1—Parkinson's disease	0.000925	0.00174	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD3—Parkinson's disease	0.000917	0.00172	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD1—Parkinson's disease	0.000907	0.0017	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR1A—Parkinson's disease	0.00089	0.00167	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM4—Parkinson's disease	0.000884	0.00166	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD3—Parkinson's disease	0.000879	0.00165	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000878	0.00165	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—TAC1—Parkinson's disease	0.000876	0.00165	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD1—Parkinson's disease	0.000859	0.00161	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000856	0.00161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR1A—Parkinson's disease	0.000853	0.0016	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM4—Parkinson's disease	0.000848	0.00159	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—TAC1—Parkinson's disease	0.00084	0.00158	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PENK—Parkinson's disease	0.000838	0.00157	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAG—Parkinson's disease	0.000838	0.00157	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD3—Parkinson's disease	0.000832	0.00156	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR7—Parkinson's disease	0.000829	0.00156	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—DRD2—Parkinson's disease	0.000829	0.00156	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD1—Parkinson's disease	0.000824	0.00155	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000821	0.00154	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000817	0.00153	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PENK—Parkinson's disease	0.000803	0.00151	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAG—Parkinson's disease	0.000803	0.00151	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—Parkinson's disease	0.000802	0.00151	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD3—Parkinson's disease	0.000798	0.0015	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000796	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR7—Parkinson's disease	0.000795	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—DRD2—Parkinson's disease	0.000795	0.00149	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000777	0.00146	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDYN—Parkinson's disease	0.000766	0.00144	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—DRD2—Parkinson's disease	0.000753	0.00141	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR7—Parkinson's disease	0.000753	0.00141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000745	0.0014	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDYN—Parkinson's disease	0.000735	0.00138	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR7—Parkinson's disease	0.000722	0.00136	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD2—Parkinson's disease	0.000722	0.00136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GFAP—Parkinson's disease	0.000721	0.00135	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM5—Parkinson's disease	0.000713	0.00134	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GFAP—Parkinson's disease	0.000691	0.0013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM5—Parkinson's disease	0.000683	0.00128	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—EDN1—Parkinson's disease	0.000664	0.00125	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—Parkinson's disease	0.000648	0.00122	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—Parkinson's disease	0.00064	0.0012	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000637	0.0012	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—Parkinson's disease	0.000636	0.00119	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGF20—Parkinson's disease	0.000625	0.00117	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADORA2A—Parkinson's disease	0.000606	0.00114	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDN1—Parkinson's disease	0.000603	0.00113	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF20—Parkinson's disease	0.000599	0.00112	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADORA2A—Parkinson's disease	0.000581	0.00109	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000581	0.00109	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—Parkinson's disease	0.000578	0.00108	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INSR—Parkinson's disease	0.000559	0.00105	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000557	0.00105	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INSR—Parkinson's disease	0.000536	0.00101	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGB—Parkinson's disease	0.000528	0.000992	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR2A—Parkinson's disease	0.000527	0.00099	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR1A—Parkinson's disease	0.000526	0.000987	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TAC1—Parkinson's disease	0.000518	0.000972	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000514	0.000966	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD1—Parkinson's disease	0.000508	0.000953	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGB—Parkinson's disease	0.000507	0.000951	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2A—Parkinson's disease	0.000505	0.000949	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR1A—Parkinson's disease	0.000504	0.000946	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TAC1—Parkinson's disease	0.000496	0.000932	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD3—Parkinson's disease	0.000492	0.000923	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD1—Parkinson's disease	0.000487	0.000914	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD3—Parkinson's disease	0.000471	0.000885	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRBK1—Parkinson's disease	0.000459	0.000862	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR7—Parkinson's disease	0.000445	0.000835	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD2—Parkinson's disease	0.000445	0.000835	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRBK1—Parkinson's disease	0.00044	0.000827	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD2—Parkinson's disease	0.000426	0.000801	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR7—Parkinson's disease	0.000426	0.000801	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF2—Parkinson's disease	0.000373	0.0007	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1R—Parkinson's disease	0.00036	0.000677	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF2—Parkinson's disease	0.000357	0.000671	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDN1—Parkinson's disease	0.000356	0.000669	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—Parkinson's disease	0.000345	0.000649	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDN1—Parkinson's disease	0.000341	0.000641	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGF—Parkinson's disease	0.000327	0.000614	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGF—Parkinson's disease	0.000314	0.000589	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2A—Parkinson's disease	0.000311	0.000585	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR2A—Parkinson's disease	0.000299	0.000561	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—Parkinson's disease	0.00029	0.000544	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOE—Parkinson's disease	0.000278	0.000521	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INS—Parkinson's disease	0.000247	0.000464	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INS—Parkinson's disease	0.000237	0.000445	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—Parkinson's disease	0.000184	0.000346	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—Parkinson's disease	0.000183	0.000344	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—Parkinson's disease	0.000177	0.000332	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—Parkinson's disease	0.000175	0.000329	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—Parkinson's disease	0.000169	0.000318	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—Parkinson's disease	0.000162	0.000305	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—Parkinson's disease	0.000108	0.000203	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—Parkinson's disease	0.000104	0.000195	CbGpPWpGaD
